Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Subcutaneous formulations of anti-CD38 antibodies and their uses

Subcutaneous formulations of anti-CD38 antibodies and their uses

US Patent 11566079 · Granted Jan 31, 2023

Estimated economic value: $575,392,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Photoactive compounds for vapor deposited organic photovoltaic devices2024
Metal coordinated photoactive compounds for transparent photovoltaic devices2024
N-hydroxyethyl didehydroazapodophyllotoxins as GBP1 inhibitors and methods of ov2023
Small molecule CMKLR1 antagonists in inflammatory disease2023
Subcutaneous formulations of anti-CD38 antibodies and their uses2023
Subcutaneous formulations of anti-CD38 antibodies and their uses2023
Subcutaneous formulations of anti-CD38 antibodies and their uses2023
Subcutaneous formulations of anti-CD38 antibodies and their uses2023
Subcutaneous formulations of anti-CD38 antibodies and their uses2023
Subcutaneous formulations of anti-CD38 antibodies and their uses2023
Multilayer nitride hard coatings2022
Intelligent data ingestion system and method for governance and security2022